logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
P

PULMONARY PHARMACOLOGY & THERAPEUTICS

IF2.8
Papers15
Citations
Journal Papers 15
Publication Date
delete
Effects of anumigilimab, an anti–G-CSF receptor mAb, after segmental LPS challenge: A Phase 1b trial in healthy volunteers
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-07-06
delete0
deleteOAAI
deleteJens M. Hohlfeld; Meike Müller; Philipp Badorrek; Laurent B. Nicolas; Oliver Vit; William G. Darby; Judith Field; Michael Larbig
deleteShare
deleteSave
Brain-derived neurotrophic factor (BDNF) signaling in respiratory disease: Mechanisms, neuroimmune crosstalk, and therapeutic implications
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-07-01
delete0
PREAI
deleteEntesar Yaseen Abdo Qaid; Idris Long
deleteShare
deleteSave
TROP2 as a Promising Therapeutic Target in Lung Cancer: Current Clinical Trial Landscape and Future Directions
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-06-09
delete0
PREAI
deleteMaosen Liu; Ruihang Luo; Yichen Liu; Yuxin Fan; Jingtao Zhang; Mingshan Liu
deleteShare
deleteSave
Synergistic induction of apoptosis in lung cancer cells via TOP2A targeting through combined dihydroartemisinin and chrysin treatment
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-05-05
delete0
PREAI
deleteHaidi Sun; Li Han; Hongwei Wu; Hongsheng Xue; Ming-Fei Lang; Jingyu Tan
deleteShare
deleteSave
Evodiamine protects against lung ischemia–reperfusion injury by attenuating SYK-associated TLR4/NLRP3 inflammasome activation and ferroptosis-related injury signatures
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-04-06
delete0
PREAI
deleteWei Peng; Baiping Ge; Rui Zhang; Yunen Liu; Changci Tong; Chenguang Dong
deleteShare
deleteSave
Evaluation of the effect of modulator therapies on medication complexity in adult cystic fibrosis patients
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-03-10
delete0
PREAI
deleteEsen Deniz Akman Ar; Nadir Yalçın; Uğur Balaban; Oğuz Karcıoğlu; Ebru Damadoğlu; Ali Fuat Kalyoncu; Kutay Demirkan
deleteShare
deleteSave
Nicotinamide N-oxide alleviates sepsis-induced acute lung injury by inhibiting ferroptosis through activation of the SIRT1/AKT signalling pathway
deletePulmonary Pharmacology & Therapeutics
IF2.8
delete2026-03-05
delete0
PREAI
deleteShujuan Liu; Mian Fu; Xiguang Liu; Yichen Jin; Liwen Fan; Qingyan Ni; Zihan Xu; Yusa Li; Jiawen Zhou; Huizhen Chen
deleteShare
deleteSave
Posaconazole attenuates arsenic trioxide toxicity and enhances safety and efficacy while reducing invasion and metastasis in non-small-cell lung cancer
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-03-01
delete0
PREAI
deleteKarami, Shima; Rabbani-Chadegani, Azra; Davoodi, Jamshid
deleteShare
deleteSave
Pulmonary safety of Staccato alprazolam in healthy participants and participants with mild asthma: Phase 1, randomized, double-blind, placebo-controlled trial
deletePulmonary Pharmacology & Therapeutics
IF2.8
delete2026-02-24
delete0
PREAI
deleteS. David Miller; Craig F. LaForce; Laura Barlow; Shikiko Watanabe; Aliceson King; Maria Burian; Hugues Chanteux
deleteShare
deleteSave
The importance of biomarkers in the treatable-trait approach to chronic airway diseases
deletePulmonary Pharmacology & Therapeutics
IF2.8
delete2026-02-02
delete0
deleteOAAI
deleteMario Cazzola; Mauro Maniscalco; Maria Gabriella Matera; Paola Rogliani
deleteShare
deleteSave
Artificial intelligence in the development of Rentosertib: A novel TNIK inhibitor for idiopathic pulmonary fibrosis - A letter to editor
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-01-21
delete0
PREAI
deleteNamboothiri, Devipriya R.; Sivanandan, Aswathy; Netto, Gladyston; Mathew, Midhun
deleteShare
deleteSave
Targeting ELK-1 transcription factor and mechanosensitive MDM4 receptor using an HCN channel blocker alleviates lung fibrosis
deletePulmonary Pharmacology & Therapeutics
IF2.8
delete2026-01-19
delete0
PREAI
deleteSahar A Helmy; Nesma A. Abd Elrazik
deleteShare
deleteSave
Echocardiographic effects of dupilumab in patients with severe type 2 asthma
deletePulmonary Pharmacology & Therapeutics
IF2.8
delete2026-01-19
delete0
deleteOAAI
deleteCorrado Pelaia; Giuseppe Armentaro; Chiara Lupia; Antonio Giacalone; Gianluca Ippolito; Daniela Pastore; Sofia Miceli; Carlo Alberto Pastura; Giandomenico Severini; Carlo Fuoco; Alberto Panza; Filippo Capilupi; Maria Rosangela Scarcelli; Giovanna Lucia Piazzetta; Emanuela Chiarella; Alessandro Vatrella; Girolamo Pelaia; Angela Sciacqua
deleteShare
deleteSave
Effectiveness of Mepolizumab and Dupilumab in patients with asthma-COPD overlap (ACO) compared to severe uncontrolled asthma (SUA): A retrospective observational cohort study
deletePulmonary Pharmacology & Therapeutics
IF2.8
delete2026-01-08
delete0
PREAI
deleteBelén Muñoz-Sánchez; Antonio León-Lloreda; David Carlos Echavarría; María Polonio-González; Juan Francisco Medina-Gallardo; Marta Ferrer-Galván; Auxiliadora Romero-Falcón; Javier Díez-Sierra; Francisco Javier Álvarez-Gutiérrez
deleteShare
deleteSave
Setting expectations with oral selexipag: an expert consensus-based approach on best practices to initiate, dose, titrate, and manage side effects (SEs) in patients with pulmonary arterial hypertension (PAH)
deletePulmonary Pharmacology & Therapeutics
IF2.8
delete2026-01-08
delete0
PREAI
deleteSheryl E. Wu; Jeremy A. Mazurek; Jennalyn D. Mayeux; Naomi G. Habib; Gurinderpal S. Doad; Christina K. Benninger; Michelle C. Cho; Paul M. Strachan; Richard M. Perry; Daisy Bridge; Medi A. Stone; Charlotte W. Oswald; Luis Val-Maranes; J. Wesley McConnell
deleteShare
deleteSave